Enveric Biosciences Inc

NASDAQ: ENVB
$1.01
+$0.10 (+11.0%)
Closing price April 12, 2024
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.